Health Dictionary Find a Doctor

Epistaxis

For patient information, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D., Liudvikas Jagminas, M.D., FACEP

Synonyms and keywords: Nose bleed; nosebleed; bloody nose

Overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D., Liudvikas Jagminas, M.D., FACEP [2] José Eduardo Riceto Loyola Junior, M.D.[3]

Overview

Epistaxis is the relatively common occurrence of hemorrhage (bleeding) from the nose, usually noticed when it drains out through the nostrils. There are two types: anterior (the most common), and posterior (less common, and more severe). Sometimes in more severe cases, the blood can come up the nasolacrimal duct and out from the eye. Fresh blood and clotted blood can also flow down into the stomach and cause nausea and vomiting.

Historical Perspective

In past centuries, people thought epistaxis happened due to internal diseases. As the medical knowledge advanced, people found out that nasal compression can stop bleeding. Hippocrates was the first one who used some instruments to stop nasal bleeding. The term epistaxis was originally derived from the Greek word epistazein (epi – above, over; stazein – to drip).

Classification

Epistaxis may be classified according to the anatomical origin of the bleeding into 2 groups: anterior and posterior. It can also be further classified into primary (if idiopathic) or secondary (if there is a known cause) and acute or chronic.

Pathophysiology

Nosebleeding happen due to tears in the mucosal lining and the many small blood vessels it contains. Fragility or injury may cause tears, while inflammation, coagulation problems, and other disorders may make the injury harder to repair. In some patients, rupture of nasal blood vessels is spontaneous.

Causes

The causes of epistaxis can be divided into idiopathic and non-idiopathic causes. There are many diseases and medications that can cause epistaxis, but it can also start spontaneously. Usually, epistaxis is not dangerous but, in some cases, it can become life threatening. Trauma is the most common cause of epistaxis.

Differentiating Epistaxis from other Diseases

Many diseases can cause epistaxis. Based on patient history and physical examination, we can diagnose a cause of epistaxis. Differentiating anterior epistaxis from posterior epistaxis may be challenging. Rhinoscopy is the best way to distinguish between anterior and posterior epistaxis. In selected cases, endoscopy may be required.

Epidemiology and demographics

Epistaxis is a prevalent symptom worldwide. About 60 percent of people experience epistaxis at least once, and about 6 percent of these people look for medical action at least once. It is more common in children and elderly patients

Risk Factors

The most common risk factor of epistaxis in trauma. Other risk factors include coagulopathies, infections and vascular abnormalities. It can occur spontaneously. Childhood and senility are unchangeable risk factors.

Screening

No screening is indicated for epistaxis in asymptomatic patients.

Natural History, Complications, and Prognosis

Although epistaxis often ceases easily, it can become challenging to stop especially in posterior epistaxis which can cause aspiration. Most of the time bleeding stops without any intervention.Prognosis is generally good, and mortality is very rare.

Diagnostic study of choice

The diagnostic study of choice to find the source of epistaxis is rhinoscopy. Cases in which rhinoscopy is ineffective in determining the vessel of bleeding, internal carotid artery (ICA) angiography is the preferred diagnostic study to find the bleeding site.

History and Symptoms

The hallmark of epistaxis is nosebleed. History of nose-picking, facial trauma, hypertension and coagulopathy may be found. The less common symptoms of epistaxis include fainting, dizziness, and hypovolemic shock.

Physical Examination

Patients with epistaxis are usually well-appearing. Physical examination of patients with epistaxis is usually remarkable for bleeding from nostrils and posterior nose bleeding.

Laboratory Findings

Laboratory findings is usually normal among patients with epistaxis, but when bleeding is heavy or physician it raises suspicion of coagulopathy. The following tests should be performed: CBC, PT, PTT, BT.

ECG

There are no ECG findings associated with epistaxis.

X-ray

There are no X-ray findings associated with epistaxis.

Echocardiography and Ultrasound

There are no echocardiographic or ultrasonographic findings associated with epistaxis.

CT Scan

Paranasal sinuses CT scan is helpful in diagnosis causes of epistaxis, when the cause is unknown, also when epistaxis is heavy and/or recurrent.

Other Imaging Findings

Rhinoscopy and nasal endoscopy may be helpful in the diagnosis of epistaxis. It can help to assess the source of bleeding, distinguish between anterior and posterior epistaxis, and plan treatment.

Other Diagnostic Studies

Bone marrow biopsy is another diagnostic study to find cause of epistaxis, particularly when leukemia is suspected.

Medical Therapy

The majority of cases of epistaxis are self-limited and require only supportive care. If there is active bleeding, compression of the nostrils is the first measure to stop bleeding. If bleeding continues, ice application and nasal packing are possible measures to control bleeding. There are other options like cautery and some vasoconstrictive agents like oxymetazoline or phenylephrine to control bleeding.

Surgery

Surgery is not the first-line treatment option for patients with epistaxis. Surgery is usually reserved for patients with either heavy active bleeding, recurrent epistaxis or non-compliant medical therapy.

Primary Prevention

Effective primary prevention measures for epistaxis include a vaporizer, nasal saline spray, and water soluble jelly, especially during winter months.

Secondary Prevention

The primary and secondary prevention strategies for epistaxis are the same.

Cost-effectiveness of Therapy

Most of the patients with epistaxis don’t need any medical procedure. Nasal compression is the best first option to stop bleeding. 95.5% of patients with epistaxis who attend emergency departments were discharged, patients were charged, on average, $1146.21 per visit.

Future or Investigational Therapies

Template:WikiDoc Sources

Historical Perspective


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.

Overview

In past centuries, it was believed that epistaxis was caused by internal diseases. As the medical knowledge advanced, it was understood that that nasal compression can stop bleeding. Hippocrates is believed to be the first to use a instrument to stop nasal bleeding. The term epistaxis was originally derived from the Greek word epistazein (epi – above, over; stazein – to drip).

Historical Perspective

  • The term epistaxis was originally derived from the Greek word epistazein (epi – above, over; stazein – to drip). [1]
  • In past centuries, it was thought that epistaxis was due to internal diseases.
  • In the late of 19th century, J. L. Little and W. Kiesselbach found that there is a plexus of vessels in the anterior part of nose which is source of most nasal bleedings.[1]
  • It was discovered empirically that nasal compression can stop bleeding. There were some beliefs that nasal bleeding could also be stopped by transfering blood to other parts of the body. Tourniquets were used for this purpose.[1]
  • Hippocrates is believed to be the first to use an instruments to stop nasal bleeding.[1]

References

  1. 1.0 1.1 1.2 1.3 Feldmann, H. (2008). “Nasenbluten in der Geschichte der Rhinologie”. Laryngo-Rhino-Otologie. 75 (02): 111–120. doi:10.1055/s-2007-997547. ISSN 0935-8943.

Template:WikiDoc Sources

Classification


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1],Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D. José Eduardo Riceto Loyola Junior, M.D.[2]

Overview

Epistaxis may be classified according to the anatomical origin of the bleeding into 2 groups: anterior and posterior. It can also be further classified into primary (if idiopathic) or secondary (if there is a known cause) and acute or chronic.

Classification

Classification according to anatomical source

Epistaxis can be classified into anterior and posterior based upon the anatomical source of bleeding[1]

Anterior epistaxis:

Posterior-epistaxis:

Classification according to time

  • Acute epistaxis: as the name implies, it is a “de novo” bleeding.
  • Chronic epistaxis : it is characterized by intermittent bleeding, that persists through a period of time.

Classification according to etiology

References

  1. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  2. 2.0 2.1 Beck R, Sorge M, Schneider A, Dietz A (2018). “Current Approaches to Epistaxis Treatment in Primary and Secondary Care”. Dtsch Arztebl Int. 115 (1–02): 12–22. doi:10.3238/arztebl.2018.0012. PMC 5778404. PMID 29345234.
  3. “StatPearls”. 2020. PMID 28613768.

Template:WikiDoc Sources

Pathophysiology


Editor in Chief:: C. Michael Gibson, M.S., M.D.. Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.José Eduardo Riceto Loyola Junior, M.D.[1]

Overview

Nosebleeding occurs due to tears in the mucosal lining and the many small blood vessels it contains. Fragility or injury may cause the tears, while inflammation, coagulation problems and other disorders may make the injury more difficult to repair. In some patients, rupture of nasal blood vessels is spontaneous.

Pathophysiology

Different causes tear vessels of the nose plexuses and lead to epistaxis:[1]

Location of the Kiesselbach’s and Woodruff’s plexus[3]


References

  1. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  2. “StatPearls”. 2020. PMID 28613768.
  3. Moon S (2018). “Comprehensive understanding of vascular anatomy for endovascular treatment of intractable oronasal bleeding”. Yeungnam Univ J Med. 35 (1): 7–16. doi:10.12701/yujm.2018.35.1.7. PMC 6784680 Check |pmc= value (help). PMID 31620565.

Template:WikiDoc Sources

[[Category:Up-To-Date]

Causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Marcelo R. Zacarkim, M.D. [2] Kiran Singh, M.D. [3] Amir Behzad Bagheri, M.D. José Eduardo Riceto Loyola Junior, M.D.[4]

Overview

The causes of epistaxis can be divided into idiopathic and non-idiopathic ones. There are many diseases and medications that can cause epistaxis but it also may be spontaneous. Usually epistaxis is not dangerous but in some cases it can become life threatening. Trauma is the most common cause of epistaxis.

Causes

Life Threatening Causes

Common Causes

Less Common Causes

There is not enough evidence that hypertension is a risk factor for epistaxis.The role of lowering blood pressure to control and prevent epistaxis remains controversial.

In the table below different causes of epistaxis are classified based on organ system.

Causes by Organ System

Cardiovascular Aneurysm of the carotid artery, atherosclerosis, blood vessel disorders, cardiopulmonary resuscitation, coarctation of the aorta, congestive heart failure, hypertension, malignant hypertension, rheumatic fever, secondary hypertension, superior vena cava syndrome, vascular disorders
Chemical / poisoning Aerosol abuse, ammonia, angiofibroma, biphenyl, borates rodenticide poisoning, brodifacoum rodenticide poisoning, bromadiolone rodenticide poisoning, brown snake rodenticide poisoning, calcium sulfate, chemical irritants, chlorophacinone rodenticide poisoning, chromates rodenticide poisoning, coumachlor rodenticide poisoning, coumafuryl rodenticide poisoning, coumatetralyl rodenticide poisoning, difenacoum rodenticide poisoning, difethialone rodenticide poisoning, diphacinone rodenticide poisoning, formaldehyde, indandione rodenticide poisoning, inhalant abuse, inhaled irritants, matikus rodenticide poisoning, metaldehyde, mouser rodenticide poisoning, mucormycosis, phosphorous, pindone rodenticide poisoning, ratak plus rodenticide poisoning, rodend rodenticide poisoning, rodenticides, solvent abuse, sulphuric acid, talon rodenticide poisoning, tetrachloroethylene, tetryl, vanadium, volak rodenticide poisoning, volid rodenticide poisoning, tobacco smoke
Dental Dental extraction
Dermatologic Benign mucosal pemphigoid, defibrination syndrome, leprosy, localized skin infection, melanoma, mucormycosis, nasal excoriation, Osler-weber-rendu disease, purpura, septal granulomas, staphylococcal furuncles, systemic lupus erythematosus, thrombocyopenic purpura
Drug Side Effect Allegra, anticoagulants, antiplatelet drug, aspirin, bicalutamide, budesonide, butorphanol, cefpodoxime, ciclesonide,clemastine fumarate, clopidogrel, caspofungin acetate, clove (herbal agent), desmopressin, diquat dibromide, febuxostat, fexofenadine, flurbiprofen, fluticasone nasal spray, heroin, histrelin, Ibuprofen, corticosteroids, ipratropium bromide, isotretinoinleflunomide, lenvatinib, loratadine, meropenem, metipranolol, miltefosine, narcotics, nasal steroids, olopatadine, oxcarbazepine, palbociclib, pennyroyal oil (herbal agent), pramipexole, prasugrel, ramucirumab, retapamulin, rifaximin, riociguat,romiplostim, sertraline, sulindac, telfast, tiagabine, thalidomide, tobramycin, topiramate, triamcinolone acetonide, trimethadione, valproic acid, warfarin
Ear Nose Throat Abnormal nasal anatomy , acute sinusitis, allergic rhinitis, antrochoanal polyps, antrostomy, barotrauma, benign nose tumors, broken nose, chronic irritation of the nasal mucosa, chronic rhinitis , chronic sinusitis common cold, deviated septum, dry nasal mucosa, epstein’s syndrome, esthesioneuroblastoma, ethmoidal polyps, hereditary haemorrhagic telangiectasia, increased nasal venous pressure, intranasal rhabdomyosarcoma, inverted papilloma, juvenile nasopharyngeal angiofibroma, maxillary sinus carcinoma, maxillofacial injury, middle ear barotrauma, nasal cancer, nasal cannula, nasal colonization with staphylococcus aureus , nasal congestion, nasal diphtheria, nasal excoriation, nasal foreign body, nasal fracture, nasal infection, nasal obstruction, nasal polyp, nasal septum deviation, nasal sprays, nasal tuberculosis, nasopharyngeal angiofibroma, nasopharyngeal carcinoma, nasal ulceration, non-allergic rhinitis, nose picking, rhinitis, rhinoplasty rhinoscleroma septal deviation, septal perforation, sinonasal undifferentiated carcinoma, sinus tumor, sinusitis, superior vena cava syndrome, trauma to littlee’s area, unilateral choanal atresia, viral rhinitis
Endocrine Acthar, cystic fibrosis, corticotropin
Environmental Cold air, dry air, environmental irritants, humidity
Gastroenterologic Cirrhosis, hepatitis, mucormycosis, progressive familial intrahepatic cholestasis, Banti’s syndrome, rhinocerebral mucormycosis, rhinocerebral zygomycosis, Von Gierke Disease, Zygomycosis
Genetic ADP platelet receptor P2Y12 deficiency, autoimmune lymphoproliferative syndrome, Banti’s syndrome, christmas disease, coarctation of the aorta, congenital afibrinogenemia, congenital hypoplastic anemia, congenital syphilis, Congential fibrinogen deficiency, connective tissue disease, cystic fibrosis, familial platelet syndrome, Fanconi’s anemia, Hemoglobin Lepore syndrome, hemophilia, Hermansky-Pudlak syndrome, inherited coagulation disorders, leukocyte adhesion deficiency, May-Hegglin anomaly, Osler-Weber-Rendu Disease, Owren parahemophilia, progressive familial intrahepatic cholestasis, prothrombin deficiency, sickle cell anemia, Von Gierke disease, Von Willebrand disease, X-linked dyserythropoietic anemia and thrombocytopenia
Hematologic Acquired coagulation disorders, acquired factor XIII deficiency, acute erythroleukemia, acute leukemia, acute lymphocytic leukemia, acute promyelocytic leukemia, anemia, aplastic anemia, autoimmune lymphoproliferative syndrome, autoimmune thrombocytopenia, Bernard-Soulier syndrome, Bing-Neel syndrome, bleeding diathesis, bleeding disorders, bleeding tendency, blood dyscrasias, christmas disease, chronic leukemia, coagulation disorders, congenital afibrinogenemia, congenital hypoplastic anemia, congential fibrinogen deficiency, defibrination syndrome, Epstein’s syndrome, factor V deficiency, factor VII deficiency, factor X deficiency, familial blood dyscrasias, familial platelet syndrome, Fanconi’s anemia, hematological malignancy, Hemoglobin Lepore syndrome, hemoglobin SC, hemophilia, Hermansky-Pudlak syndrome, idiopathic thrombocytopenic purpura, Inability of the blood to clot, leukaemia, lymphomatoid granulomatosis, May-Hegglin anomaly, myelodysplastic syndromes, myeloproliferative diseases, Owren parahemophilia, pancytopenia, people with blood group O, platelet disorders, polycythemia vera, purpura, sickle cell anemia, stuart factor deficiency, superior vena cava syndrome, thrombasthenia, thrombocytopenic purpura, thrombocytopathy, thrombocytopenia, Von Willebrand disease, Waldenstrom macroglobulinemia, X-linked dyserythropoietic anemia and thrombocytopenia
Iatrogenic Adenoidectomy, antrostomy, dental extraction, endoscopic sinus procedures, facial surgery, nasal cannula, nasal surgery, nasogastric tube placement, nasotracheal intubation, Orbital decompression, postoperative, rhinoplasty, septoplasty, sinus surgery, turbinectomy
Infectious Disease Argentinean hemorrhagic fever, Bolivian hemorrhagic fever, congenital syphilis, dengue hemorrhagic fever, Hantavirosis, hepatitis, idiopathic fibrosing mediastinitis, infectious diseases, inflammatory disorders, leprosy, localized skin infection, Machupo virus, mucocutaneous leishmaniasis, mucormycosis, nasal diphtheria, nasal infection, Omsk hemorrhagic fever, nasal tuberculosis, pertussis, relapsing fever, respiratory tract infection, rhinocerebral mucormycosis, rhinocerebral zygomycosis, rheumatic fever, rhinoscleroma, rhinosporidiosis, scleroma, sinusitis, Stachybotrys chartarum, Soft tissue infection, Staphylococcal furuncles, Streptococcus pyogenes infection, systemic infection with nasal congestion, tuberculosis, typhoid fever, viral rhinitis, viral upper respiratory infections, Weil syndrome, whooping cough, zygomycosis
Musculoskeletal / Ortho No underlying causes
Neurologic Acute cholinergic dysautonomia, Bing-Neel syndrome, head injury, Osler-Weber-Rendu syndrome
Nutritional / Metabolic ADP platelet receptor p2y12 deficiency, clove (herbal agent), cystic fibrosis, excessive dieting, ginseng, glycogen storage disease, malnutrition, rapid weight loss, vitamin C deficiency, vitamin K deficiency, Von Gierke disease
Obstetric/Gynecologic Menopause, pregnancy
Oncologic Acute erythroleukemia, acute leukemia, acute lymphocytic leukemia, acute promyelocytic leukemia, adenoid cystic carcinoma, angiofibroma, chronic leukemia, esthesioneuroblastoma, hemangioma, hematological malignancy, Intranasal rhabdomyosarcoma, inverted papilloma, juvenile nasopharyngeal angiofibroma, leukaemia, maxillary sinus carcinoma, melanoma, myelodysplastic syndromes, myeloproliferative diseases, nasal cancer, nasal type natural killer/t-cell lymphoma, nasopharyngeal angiofibroma, nasopharyngeal cancers, nasopharyngeal carcinoma, neoplasm, pindborg tumor, polycythemia vera, rhabdomyosarcoma, Sinonasal undifferentiated carcinoma, squamous cell carcinoma, Waldenstrom macroglobulinemia
Opthalmologic Orbital decompression
Overdose / Toxicity Alcohol abuse, chronic usage of nasal sprays, chronic vitamin A toxicity, cocaine, heroin, narcotics
Psychiatric Aerosol abuse, alcohol abuse, child abuse, inhalant abuse, solvent abuse, volatile inhalants
Pulmonary Asphyxiation, barotrauma, common cold, cystic fibrosis, idiopathic fibrosing mediastinitis, pertussis, respiratory tract infection, sarcoidosis, Wegener’s granulomatosis, Whooping cough
Renal / Electrolyte Chronic kidney disease, Epstein’s syndrome, renal artery stenosis, renal dialysis, renal disease, systemic lupus erythematosus, Wegener’s granulomatosis
Rheum / Immune / Allergy Allergic rhinitis, allergies, autoimmune lymphoproliferative syndrome, autoimmune thrombocytopenia|autoimmune thrombocytopenia, benign mucosal pemphigoid, immune thrombocytopenic purpura, leukocyte adhesion deficiency, polychondritis, rheumatic fever, rhinitis, sarcoidosis, systemic lupus erythematosus, Wegener’s granulomatosis
Sexual No underlying causes
Trauma Barotrauma, blunt trauma, broken nose, facial trauma, head injury, maxillofacial injury, nasal fracture, post-traumatic pseudoaneurysm, Skull fracture, sphenoidal fracture, trauma to littlee’s area
Urologic Inverted papilloma
Miscellaneous Foreign bodies, pennyroyal oil

Causes in Alphabetical Order

References

  1. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  2. Schmoldt A, Benthe HF, Haberland G (1975). “Digitoxin metabolism by rat liver microsomes”. Biochem Pharmacol. 24 (17): 1639–41. PMID doi:10.1016/j.otc.2008.01.003 Check |pmid= value (help).

Template:WikiDoc Sources

Differentiating Epistaxis from other Diseases

Editor in Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.

Overview

Many diseases can cause epistaxis. Based on patient history and physical examination we can diagnose the cause of epistaxis. The challenging part is differentiating anterior epistaxis from posterior epistaxis. Rhinoscopy is the best way to distinguish between anterior and posterior epistaxis. In selected cases, endoscopy may be required.

Differentiating Epistaxis from other Diseases

Epistaxis can be differentiated between anterior and posterior epistaxis.[1] [2]

The more common and important causes of epistaxis are listed below:[3]

References

  1. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  2. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). “Clinical Practice Guideline: Nosebleed (Epistaxis)”. Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  3. “StatPearls”. 2020. PMID 28613768.

Template:WikiDoc Sources

Epidemiology and Demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D. José Eduardo Riceto Loyola Junior, M.D.[2]

Overview

Epistaxis is a prevalent symptom worldwide. About 60 percent of people experience epistaxis at least once in their lifetime, and about 6 percent of these people seek medical attention. It is more common in children and elderly patients.

Epidemiology and demographics

Incidence

  • The incidence of patients with epistaxis, who required inpatient treatment to control bleeding was estimated to be 42 cases per 100,000 for men, 28 cases per 100,000 for women. For men over 85 years, the incidence is 222 per 100,000 in Thuringia, Germany.[1]
  • Only 6-10% of the patients who experience epistaxis seek medical help.[2]

Prevalence

  • About 60 percent of Americans experienced epistaxis at least once, and about 6 percent of people seek medical attention. [4][2]

Case-fatality rate/Mortality rate

Age

Race

  • Based on some studies epistaxis is more common in Caucasian compared with African-Americans.[6]

Gender


References

  1. Kallenbach, Max; Dittberner, Andreas; Boeger, Daniel; Buentzel, Jens; Kaftan, Holger; Hoffmann, Kerstin; Jecker, Peter; Mueller, Andreas; Radtke, Gerald; Guntinas-Lichius, Orlando (2020). “Hospitalization for epistaxis: a population-based healthcare research study in Thuringia, Germany”. European Archives of Oto-Rhino-Laryngology. 277 (6): 1659–1666. doi:10.1007/s00405-020-05875-2. ISSN 0937-4477.
  2. 2.0 2.1 Beck R, Sorge M, Schneider A, Dietz A (2018). “Current Approaches to Epistaxis Treatment in Primary and Secondary Care”. Dtsch Arztebl Int. 115 (1–02): 12–22. doi:10.3238/arztebl.2018.0012. PMC 5778404. PMID 29345234.
  3. 3.0 3.1 Pallin, Daniel J.; Chng, Yi-Mei; McKay, Mary Patricia; Emond, Jennifer A.; Pelletier, Andrea J.; Camargo, Carlos A. (2005). “Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001”. Annals of Emergency Medicine. 46 (1): 77–81. doi:10.1016/j.annemergmed.2004.12.014. ISSN 0196-0644.
  4. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). “Clinical Practice Guideline: Nosebleed (Epistaxis)”. Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  5. Anghel AG, Soreanu CC, Dumitru M, Anghel I (2014). “Treatment Options for Severe Epistaxis, the Experience of Coltea ENT Clinic”. Maedica (Buchar). 9 (2): 179–82. PMC 4296762. PMID 25705275.
  6. Mauer, A. C.; Khazanov, N. A.; Levenkova, N.; Tian, S.; Barbour, E. M.; Khalida, C.; Tobin, J. N.; Coller, B. S. (2011). “Impact of sex, age, race, ethnicity and aspirin use on bleeding symptoms in healthy adults”. Journal of Thrombosis and Haemostasis. 9 (1): 100–108. doi:10.1111/j.1538-7836.2010.04105.x. ISSN 1538-7933.
  7. Côrte, Filipa Camacho; Orfao, Tiago; Dias, Cláudia Camila; Moura, Carla Pinto; Santos, Margarida (2018). “Risk factors for the occurrence of epistaxis: Prospective study”. Auris Nasus Larynx. 45 (3): 471–475. doi:10.1016/j.anl.2017.07.021. ISSN 0385-8146.

Template:WikiDoc Sources

Risk Factors


Editor in Chief: C. Michael Gibson, M.S., M.D. [[1]], Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D. José Eduardo Riceto Loyola Junior, M.D.[1]

Overview

The most common risk factor of epistaxis is trauma. Other risk factors include coagulopathies, infections and vascular abnormalities. It can occur spontaneously. Childhood and senility are unchangeable risk factors.

Risk Factors

  • Hypertension may be associated with epistaxis. A study has shown that incidence rates for epistaxis were significantly higher in the hypertensive patients, and they required posterior nasal packing more often than the control group (1.9% vs. 0.4%).[4]

References

  1. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). “Clinical Practice Guideline: Nosebleed (Epistaxis)”. Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  2. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  3. Douglas, Richard; Wormald, Peter-John (2007). “Update on epistaxis”. Current Opinion in Otolaryngology & Head and Neck Surgery. 15 (3): 180–183. doi:10.1097/MOO.0b013e32814b06ed. ISSN 1068-9508.
  4. Byun H, Chung JH, Lee SH, Ryu J, Kim C, Shin JH (2020). “Association of Hypertension With the Risk and Severity of Epistaxis”. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2020.2906. PMC 7489409 Check |pmc= value (help). PMID 32910190 Check |pmid= value (help).

Template:WikiDoc Sources

Screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.

Overview

No screening is indicated for epistaxis in asymptomatic patients.

Screening

No screening is indicated for epistaxis in asymptomatic patients.

Template:WikiDoc Sources

Natural History, Complications and Prognosis


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Amir Behzad Bagheri, M.D.

Overview

Although epistaxis often ceases easily, it can become challenging to stop especially in posterior epistaxis which can cause aspiration. Most of the time bleeding stops without any intervention. Prognosis is generally good, and mortality is very rare.

Natural History, Complications, and Prognosis

Natural History

There are two types of epistaxis:[1][2][3]

Complications

Prognosis

References

  1. Pallin, Daniel J.; Chng, Yi-Mei; McKay, Mary Patricia; Emond, Jennifer A.; Pelletier, Andrea J.; Camargo, Carlos A. (2005). “Epidemiology of Epistaxis in US Emergency Departments, 1992 to 2001”. Annals of Emergency Medicine. 46 (1): 77–81. doi:10.1016/j.annemergmed.2004.12.014. ISSN 0196-0644.
  2. Krulewitz, Neil Alexander; Fix, Megan Leigh (2019). “Epistaxis”. Emergency Medicine Clinics of North America. 37 (1): 29–39. doi:10.1016/j.emc.2018.09.005. ISSN 0733-8627.
  3. Tunkel, David E.; Anne, Samantha; Payne, Spencer C.; Ishman, Stacey L.; Rosenfeld, Richard M.; Abramson, Peter J.; Alikhaani, Jacqueline D.; Benoit, Margo McKenna; Bercovitz, Rachel S.; Brown, Michael D.; Chernobilsky, Boris; Feldstein, David A.; Hackell, Jesse M.; Holbrook, Eric H.; Holdsworth, Sarah M.; Lin, Kenneth W.; Lind, Meredith Merz; Poetker, David M.; Riley, Charles A.; Schneider, John S.; Seidman, Michael D.; Vadlamudi, Venu; Valdez, Tulio A.; Nnacheta, Lorraine C.; Monjur, Taskin M. (2020). “Clinical Practice Guideline: Nosebleed (Epistaxis)”. Otolaryngology–Head and Neck Surgery. 162 (1_suppl): S1–S38. doi:10.1177/0194599819890327. ISSN 0194-5998.
  4. Ryu, Taeha; Kim, Dong Hyuck; Byun, Sung Hye (2018). “Fiberoptic bronchoscopic treatment of blood aspiration and use of sugammadex in a patient with epistaxis”. Medicine. 97 (15): e0428. doi:10.1097/MD.0000000000010428. ISSN 0025-7974.
  5. Murer, Karin; Holzmann, David; Burkhardt, Jan-Karl; Soyka, Michael Benjamin (2015). “An unusual complication of epistaxis: cerebral abscess formation after anterior ethmoidal artery ligation”. BMJ Case Reports: bcr2015213389. doi:10.1136/bcr-2015-213389. ISSN 1757-790X.

Template:WikiDoc Sources

Diagnosis

Diagnosis

History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | X-ray | CT | MRI | Echocardiography and Ultrasound | Other Imaging Findings | Other Diagnostic Studies

Treatment

Treatment

Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies

Case Studies

Case Studies

Case #1

Related Chapters

Template:WH Template:WS

Looking for the patient version?

Back to the patient-friendly article

© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH